Security
Astrana Health Inc. Common Stock · ASTH
ASTHNASDAQCommon stockCurrentCIK 1083446Updated Nov 14, 2026
ASTH price & chart
Loading TradingView…
NASDAQ:ASTH on TradingView ↗About the company
Astrana Health is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's perspective, Astrana combines its scalable care delivery infrastructure, proprietary technology platform, and aligned provider networks to enable proactive, preventive care at scale - improving patient outcomes, enhancing patient experiences, supporting provider well-being, and driving greater value across the healthcare system.
In the news
No coverage from other publishers is available.
Recent filings
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
Material Cybersecurity Incidents
Items 1.05
Regulation FD Disclosure
Items 7.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q3 2023 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 2,237,186,000Source | 1,285,376,000Source | 1,073,261,000Source | 2,282,080,000Source | 1,442,350,000Source | 1,252,471,000Source | 1,331,256,000Source | 1,226,277,000Source | 2,218,661,000Source | 1,354,894,000Source | 933,361,000Source | 922,659,000Source |
| Property, Plant and Equipment, NetUSD | — | — | — | 62,567,000Source | — | — | — | — | 57,332,000Source | — | — | — |
| GoodwillUSD | 863,266,000Source | 409,711,000Source | 275,528,000Source | 886,995,000Source | 416,917,000Source | 409,581,000Source | 416,386,000Source | 410,267,000Source | 865,305,000Source | 419,253,000Source | 278,831,000Source | 245,757,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 285,060,000Source | 109,108,000Source | 74,209,000Source | 243,312,000Source | 105,737,000Source | 116,231,000Source | 111,916,000Source | 119,707,000Source | 270,968,000Source | 118,179,000Source | 71,648,000Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 462,227,000Source | 347,994,000Source | 273,941,000Source | 400,792,000Source | 339,703,000Source | 325,310,000Source | 258,517,000Source | 334,796,000Source | 429,474,000Source | 288,455,000Source | 293,807,000Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 381,215,000Source | — | — | 465,080,000Source | 348,730,000Source | — | — | — | 374,465,000Source | — | — | 1,007,000Source |
| Assets, CurrentUSD | 883,629,000Source | 596,990,000Source | 476,229,000Source | 919,160,000Source | 729,152,000Source | 570,349,000Source | 613,270,000Source | 538,810,000Source | 863,313,000Source | 638,496,000Source | 461,507,000Source | 445,423,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 23,162,000Source | 20,506,000Source | 13,953,000Source | 25,857,000Source | 21,754,000Source | 17,417,000Source | 23,711,000Source | 17,281,000Source | 26,264,000Source | 22,861,000Source | 17,450,000Source | — |
| Operating Lease, Right-of-Use AssetUSD | 33,936,000Source | 33,119,000Source | 21,482,000Source | 39,194,000Source | 30,631,000Source | 28,792,000Source | 30,698,000Source | 39,152,000Source | 35,738,000Source | 32,601,000Source | 37,396,000Source | — |
| Other Assets, NoncurrentUSD | 23,356,000Source | 8,878,000Source | 8,586,000Source | 27,554,000Source | 30,450,000Source | 9,289,000Source | 30,512,000Source | 4,067,000Source | 22,528,000Source | 16,021,000Source | 1,877,000Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,682,462,000Source | 778,269,000Source | 457,621,000Source | 1,683,501,000Source | 904,404,000Source | 773,775,000Source | 813,550,000Source | 773,859,000Source | 1,660,327,000Source | 840,726,000Source | 522,593,000Source | 396,967,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 49,000Source | 48,000Source | 47,000Source | 49,000Source | 49,000Source | 48,000Source | 49,000Source | 48,000Source | 49,000Source | 48,000Source | 47,000Source | — |
| Additional Paid in CapitalUSD | 473,008,000Source | 411,334,000Source | 362,889,000Source | 487,820,000Source | 463,203,000Source | 401,686,000Source | 452,439,000Source | 395,473,000Source | 470,863,000Source | 426,389,000Source | 371,037,000Source | — |
| Retained Earnings (Accumulated Deficit)USD | 302,486,000Source | 293,234,000Source | 230,778,000Source | 342,355,000Source | 302,209,000Source | 277,140,000Source | 292,880,000Source | 257,969,000Source | 308,379,000Source | 286,283,000Source | 243,134,000Source | 151,010,000Source |
| Stockholders' Equity Attributable to ParentUSD | 775,543,000Source | 704,616,000Source | 593,714,000Source | 830,224,000Source | 765,461,000Source | 678,874,000Source | 745,368,000Source | 653,490,000Source | 779,291,000Source | 712,720,000Source | 614,218,000Source | 472,638,000Source |
| Liabilities and EquityUSD | 2,237,186,000Source | 1,285,376,000Source | 1,073,261,000Source | 2,282,080,000Source | 1,442,350,000Source | 1,252,471,000Source | 1,331,256,000Source | 1,226,277,000Source | 2,218,661,000Source | 1,354,894,000Source | 933,361,000Source | — |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 629,930,000Source | 312,928,000Source | 202,957,000Source | 747,639,000Source | 459,746,000Source | 309,825,000Source | 361,268,000Source | 355,272,000Source | 615,273,000Source | 365,608,000Source | 218,674,000Source | 155,542,000Source |
| Operating Lease, Liability, CurrentUSD | 7,181,000Source | 5,241,000Source | 3,528,000Source | 8,938,000Source | 5,319,000Source | 4,884,000Source | 4,979,000Source | 5,007,000Source | 7,809,000Source | 5,350,000Source | 4,607,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | 30,171,000Source | 31,162,000Source | 21,006,000Source | 33,975,000Source | 28,714,000Source | 27,092,000Source | 28,963,000Source | 37,716,000Source | 31,552,000Source | 30,654,000Source | 36,289,000Source | — |
| Deferred Income Tax Liabilities, NetUSD | 4,429,000Source | 2,857,000Source | 12,145,000Source | 8,795,000Source | 2,593,000Source | 3,250,000Source | 4,197,000Source | 3,756,000Source | 5,491,000Source | 4,555,000Source | 4,072,000Source | 30,888,000Source |
| Other Liabilities, NoncurrentUSD | 15,906,000Source | 7,460,000Source | 14,105,000Source | 10,442,000Source | 12,294,000Source | 7,723,000Source | 14,685,000Source | 7,652,000Source | 17,107,000Source | 14,003,000Source | 3,586,000Source | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 13,532,000Source | 5,003,000Source | 3,995,000Source | 10,616,000Source | 6,067,000Source | 4,134,000Source | 5,071,000Source | 4,485,000Source | 14,005,000Source | 4,006,000Source | 2,433,000Source | — |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 5,491,000Source | 4,555,000Source | 4,072,000Source | — |
| Dividends Payable, CurrentUSD | — | 638,000Source | 638,000Source | — | — | 638,000Source | 638,000Source | 638,000Source | — | 638,000Source | 638,000Source | — |
| Dividends PayableUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Long-term Debt, Current MaturitiesUSD | 47,865,000Source | 15,000,000Source | 2,991,000Source | 53,848,000Source | 12,500,000Source | 17,000,000Source | 12,500,000Source | 20,750,000Source | 47,865,000Source | 9,375,000Source | 19,500,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 1,002,026,000Source | 423,119,000Source | 206,213,000Source | 882,650,000Source | 401,057,000Source | 425,006,000Source | 403,894,000Source | 368,448,000Source | 990,904,000Source | 425,299,000Source | 258,939,000Source | — |
| Preferred Stock, Value, Issued | —Source | — | — | —Source | —Source | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 1,077,000Source | 18,981,000Source | 18,452,000Source | 10,216,000Source | 21,866,000Source | 6,221,000Source | 24,076,000Source | 49,932,000Source | 57,849,000Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | — | 6,849,000Source | 45,749,000Source | 27,927,000Source | 17,748,000Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | 7,811,000Source | 38,601,000Source | 34,536,000Source | 22,040,000Source | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | — | 10,368,000Source | 9,424,000Source | 44,388,000Source | 26,735,000Source | — |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -4,287,000Source | -4,250,000Source | -12,444,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | — | 16,627,000Source | 114,597,000Source | 52,198,000Source | 68,227,000Source | — |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | 0Source | 548,604,000Source | 146,260,000Source | 6,512,000Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | -2,394,000Source | -538,999,000Source | -192,395,000Source | -65,523,000Source | — |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | — | -676,000Source | -6,319,000Source | — | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | 3,070,000Source | 10,106,000Source | 8,031,000Source | 28,529,000Source | — |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | — | 4,052,000Source | 6,169,000Source | 4,662,000Source | — | — |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | 10,600,000Source | 25,600,000Source | 900,000Source | 10,192,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | — | -44,170,000Source | 569,346,000Source | 135,146,000Source | 3,421,000Source | — |
| Payments of Ordinary Dividends, Common StockUSD | — | — | — | — | — | — | — | 5,455,000Source | 7,885,000Source | 4,036,000Source | 62,074,000Source | — |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | — | -1,190,000Source | 2,307,000Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | — | -29,937,000Source | 144,944,000Source | -5,051,000Source | 6,125,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 464,326,000Source | 348,640,000Source | 405,743,000Source | 340,350,000Source | 325,956,000Source | 259,164,000Source | 434,045,000Source | 289,101,000Source | 294,152,000Source | — |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | 7,360,000Source | 45,767,000Source | 30,419,000Source | 14,251,000Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 7,700,000Source | 6,200,000Source | 11,800,000Source | 11,700,000Source | 7,390,000Source | 7,800,000Source | 38,600,000Source | 34,536,000Source | 22,040,000Source | — |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | 691,000Source | 4,050,000Source | 1,828,000Source | 1,061,000Source | — |
| Amortization of Intangible AssetsUSD | — | — | 14,200,000Source | 6,700,000Source | 13,800,000Source | 6,200,000Source | — | 6,300,000Source | 40,700,000Source | 25,600,000Source | 12,700,000Source | — |
| Dividends Payable, CurrentUSD | — | — | — | 638,000Source | — | — | 638,000Source | 638,000Source | — | 638,000Source | 638,000Source | — |
| Dividends PayableUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — | — |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Equity Securities, FV-NI, Gain (Loss)USD | — | — | — | 68,000Source | — | — | -85,000Source | — | — | -135,000Source | 6,629,000Source | — |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | — | 65,000Source | — | — | 0Source | — | — | -146,000Source | -4,052,000Source | — |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | — | — | — | 3,000Source | — | — | -85,000Source | 5,000Source | — | 11,000Source | 2,577,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | -375,000Source | — | 2,398,000Source | — | — |
| General and Administrative ExpenseUSD | — | — | 62,387,000Source | 37,803,000Source | 54,150,000Source | 50,725,000Source | 35,953,000Source | 43,897,000Source | 217,256,000Source | 154,111,000Source | 112,597,000Source | — |
| GoodwillUSD | — | — | 863,266,000Source | 409,711,000Source | 886,995,000Source | 416,917,000Source | 409,581,000Source | 416,386,000Source | 865,305,000Source | 419,253,000Source | 278,831,000Source | 245,757,000Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | — |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | 0Source | 0Source | 0Source | 0Source | — | 0Source | 0Source | 0Source | — | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | — |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 1,019,000Source | 1,353,000Source | 548,000Source | 381,000Source | 902,000Source | -867,000Source | 1,708,000Source | 4,451,000Source | 5,579,000Source | — |
| Income Tax Expense (Benefit)USD | — | — | 4,594,000Source | 7,831,000Source | 8,758,000Source | 6,609,000Source | 10,031,000Source | 3,383,000Source | 15,530,000Source | 30,886,000Source | 31,989,000Source | — |
| InterestExpenseNonoperatingUSD | — | — | 17,718,000Source | 8,856,000Source | 15,997,000Source | 7,382,000Source | 8,587,000Source | 7,308,000Source | 49,928,000Source | 33,097,000Source | — | — |
| Investment Income, InterestUSD | — | — | 3,522,000Source | 3,778,000Source | 5,907,000Source | 2,336,000Source | 3,513,000Source | 2,312,000Source | 12,157,000Source | 14,508,000Source | 14,208,000Source | — |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | — | — | — | — | — | — | — | 383,821,000Source | 1,894,902,000Source | 1,262,428,000Source | 852,935,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 373,000Source | 16,094,000Source | 19,739,000Source | 9,423,000Source | 19,171,000Source | 6,692,000Source | 22,487,000Source | 43,149,000Source | 60,717,000Source | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 704,000Source | 2,887,000Source | -1,287,000Source | 793,000Source | 2,695,000Source | -471,000Source | 1,589,000Source | 6,783,000Source | -2,868,000Source | — |
| Nonoperating Income (Expense)USD | — | — | -13,539,000Source | -1,613,000Source | -7,112,000Source | -3,515,000Source | 1,831,000Source | -10,979,000Source | -38,919,000Source | -8,532,000Source | 5,225,000Source | — |
| Other Nonoperating Income (Expense)USD | — | — | 445,000Source | 2,673,000Source | -2,302,000Source | 1,136,000Source | 6,126,000Source | -5,072,000Source | -2,788,000Source | 4,875,000Source | 6,121,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Proceeds from (Payments to) Noncontrolling InterestsUSD | — | — | — | — | — | — | — | 0Source | — | 150,000Source | 0Source | — |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | — | — | — | — | — | — | — | 0Source | 201,000Source | — |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | -807,000Source | -561,000Source | 4,732,000Source | 14,000Source | -123,000Source | -44,000Source | -68,000Source | 731,000Source | -4,581,000Source | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 956,048,000Source | 478,710,000Source | 972,520,000Source | 654,808,000Source | 486,265,000Source | 620,390,000Source | 3,181,769,000Source | 2,034,540,000Source | 1,386,661,000Source | 1,144,163,000Source |
| Operating Income (Loss)USD | — | — | 19,210,000Source | 28,425,000Source | 34,322,000Source | 20,340,000Source | 30,066,000Source | 20,583,000Source | 78,525,000Source | 89,350,000Source | 84,613,000Source | 104,265,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 445,000Source | 2,673,000Source | -2,302,000Source | 1,136,000Source | 6,126,000Source | -5,072,000Source | -2,788,000Source | 4,875,000Source | 6,121,000Source | 3,944,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 5,671,000Source | 26,812,000Source | 27,210,000Source | 16,825,000Source | 31,897,000Source | 9,604,000Source | 39,606,000Source | 80,818,000Source | 89,838,000Source | 86,616,000Source |
| Income Tax Expense (Benefit)USD | — | — | 4,594,000Source | 7,831,000Source | 8,758,000Source | 6,609,000Source | 10,031,000Source | 3,383,000Source | 15,530,000Source | 30,886,000Source | 31,989,000Source | 40,875,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 704,000Source | 2,887,000Source | -1,287,000Source | 793,000Source | 2,695,000Source | -471,000Source | 1,589,000Source | 6,783,000Source | -2,868,000Source | 570,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 373,000Source | 16,094,000Source | 19,739,000Source | 9,423,000Source | 19,171,000Source | 6,692,000Source | 22,487,000Source | 43,149,000Source | 60,717,000Source | 45,171,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.01Source | 0.34Source | 0.4Source | 0.19Source | 0.4Source | 0.14Source | 0.46Source | 0.91Source | 1.3Source | 1Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.01Source | 0.33Source | 0.4Source | 0.19Source | 0.4Source | 0.14Source | 0.46Source | 0.9Source | 1.29Source | 0.99Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 49,217,134Source | 47,686,841Source | 49,115,835Source | 49,187,885Source | 47,615,096Source | 48,470,682Source | 49,075,727Source | 47,597,295Source | 46,553,256Source | 44,971,143Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 49,473,417Source | 48,223,788Source | 49,778,028Source | 49,470,677Source | 47,978,491Source | 48,850,666Source | 49,369,685Source | 47,974,334Source | 46,943,140Source | 45,602,415Source |
| Interest Expense (non-operating)USD | — | — | 17,718,000Source | 8,856,000Source | 15,997,000Source | 7,382,000Source | 8,587,000Source | 7,308,000Source | 49,928,000Source | 33,097,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 14,200,000Source | 6,700,000Source | 13,800,000Source | 6,200,000Source | — | 6,300,000Source | 40,700,000Source | 25,600,000Source | 12,700,000Source | 13,700,000Source |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and AmortizationUSD | — | — | 858,856,000Source | 405,218,000Source | 868,498,000Source | 576,839,000Source | 412,805,000Source | 549,061,000Source | 2,840,239,000Source | 1,763,152,000Source | 1,171,703,000Source | 944,685,000Source |
| Cost, Depreciation and AmortizationUSD | — | — | 15,595,000Source | 7,264,000Source | 15,550,000Source | 6,904,000Source | 7,441,000Source | 6,849,000Source | 45,749,000Source | 27,927,000Source | 17,748,000Source | 17,543,000Source |
| Costs and ExpensesUSD | — | — | 936,838,000Source | 450,285,000Source | 938,198,000Source | 634,468,000Source | 456,199,000Source | 599,807,000Source | 3,103,244,000Source | 1,945,190,000Source | 1,302,048,000Source | 1,039,898,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 19,817,000Source | 35,136,000Source | 44,433,000Source | 55,153,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | — | — | 5,000,000Source | 2,300,000Source | 5,100,000Source | 3,700,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | — | 65,000Source | — | — | 0Source | — | — | -146,000Source | -4,052,000Source | 2,272,000Source |
| General and Administrative ExpenseUSD | — | — | 62,387,000Source | 37,803,000Source | 54,150,000Source | 50,725,000Source | 35,953,000Source | 43,897,000Source | 217,256,000Source | 154,111,000Source | 112,597,000Source | 77,670,000Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 1,019,000Source | 1,353,000Source | 548,000Source | 381,000Source | 902,000Source | -867,000Source | 1,708,000Source | 4,451,000Source | 5,579,000Source | 5,622,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | 8,587,000Source | — | — | — | 16,102,000Source | 7,920,000Source |
| Investment Income, InterestUSD | — | — | 3,522,000Source | 3,778,000Source | 5,907,000Source | 2,336,000Source | 3,513,000Source | 2,312,000Source | 12,157,000Source | 14,508,000Source | 14,208,000Source | 1,976,000Source |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | — | — | — | — | — | — | — | 383,821,000Source | 1,894,902,000Source | 1,262,428,000Source | 852,935,000Source | 651,831,000Source |
| Nonoperating Income (Expense)USD | — | — | -13,539,000Source | -1,613,000Source | -7,112,000Source | -3,515,000Source | 1,831,000Source | -10,979,000Source | -38,919,000Source | -8,532,000Source | 5,225,000Source | -17,649,000Source |
Offerings
Registration 333-294756
Registration 333-294757
Filing attachments
tm2629047d1_ex99-1.htm · 8-K · 2026-11-05
Exhibit 99.1 Astrana Health, Inc. Reports Third Quarter 2026 Results Company to Host Conference Call on Thursday, November 5, 2026, at 2:30 p.m. PT/5:30 p.m. ET Reports record revenue of $1,023.6 million, up 7% year-over-year, net income of $20.3 million, up 1,782% year-over-year, and record adjusted EBITDA(1) of $77.2 million, up 13% year-over-year for the three months ended September 30, 2026 Reports net cash provided by operating activities of $117.1 million and free cash flow…
Read attachment ↗tm2629047d1_ex99-2.htm · 8-K · 2026-11-05
Exhibit 99.2 November 2026 Third Quarter 2026 Earnings Supplement ────────────────────────────────────────── 2 Forward Looking Statements Use of Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements include any statements about the Company's business, financial condition, operatin…
Read attachment ↗tm2625986d1_ex99-1.htm · 8-K · 2026-09-23
Exhibit 99.1 September 2026 BS1 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward - looking statements include any statements about the Company's business, financial condition, operating results, plans, objectives, expectations and intentions, expansion plans, estimates of our total addressable market, our …
Read attachment ↗tm2625392d1_ex99-1.htm · 8-K · 2026-09-15
EX-99.1 2 tm2625392d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Investor Presentation September 2026 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward - looking statements include any statements about the Company's business, financial condition, operating results, plans, objectives, expectations and intentio…
Read attachment ↗tm2622348d1_ex99-1.htm · 8-K · 2026-08-06
EX-99.1 2 tm2622348d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Astrana Health, Inc. Reports Second Quarter 2026 Results Company to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m. ET Reports revenue of $972.5 million, up 49% year-over-year, net income of $18.5 million, up 81% year-over-year, and adjusted EBITDA(1) of $68.9 million, up 43% year-over-year for the three months ended June 30, 2026 Reports net cash provided by operating activities of $100.8 mi…
Read attachment ↗tm2622348d1_ex99-2.htm · 8-K · 2026-08-06
EX-99.2 3 tm2622348d1_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 August 2026 Second Quarter 2026 Earnings Supplement 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward - looking statements include any statements about the Company's business, financial condition, operating results, plans, objectives, expectatio…
Read attachment ↗